drovelis
gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - pohlavné hormóny a modulátory z genitálny systém, - oral contraceptive.
lydisilka
estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - pohlavné hormóny a modulátory z genitálny systém, - orálna antikoncepcia. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.
tybost
gilead sciences ireland uc - cobicistat - hiv infekcie - antivirotiká na systémové použitie - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
angeliq
bayer ag - drospirenón a estrogén - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
cleosensa 0,03 mg/3 mg
actavis group ptc ehf., island - drospirenón a etinylestradiol - 17 - anticoncipientia
softine 0,03 mg/3 mg filmom obalené tablety
theramex ireland limited, Írsko - drospirenón a etinylestradiol - 17 - anticoncipientia
softinelle 0,02 mg/3 mg filmom obalené tablety
theramex ireland limited, Írsko - drospirenón a etinylestradiol - 17 - anticoncipientia
cleodette 0,02 mg/3 mg
actavis group ptc ehf., island - drospirenón a etinylestradiol - 17 - anticoncipientia
cleonita 0,02 mg/3 mg
actavis group ptc ehf., island - drospirenón a etinylestradiol - 17 - anticoncipientia
stribild
gilead sciences ireland uc - elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate - hiv infekcie - antivirals for treatment of hiv infections, combinations, antivirals for systemic use - liečbu vírusu ľudskej imunodeficiencie 1 (hiv-1) infekcie u dospelých vo veku 18 rokov a nad antiretrovírusovej liečby alebo ktorí sú infikovaní vírusom hiv 1 bez známe mutácie spojené s rezistenciou voči ktorejkoľvek z troch antiretrovírusovými látkami v lieku stribild.